Veeva SystemsVEEV +0.22%83 9-Day RSI is 70.05 as of Jul. 11, 2026. GuruFocus rates VEEV with a GF Score™ of 83/100 and a GF Value™ of $286.74 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 698 Healthcare Providers & Services companies, Veeva Systems ranks worse than 88.54% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-11), Veeva Systems's 9-Day RSI is 70.05.
The industry rank for Veeva Systems's 9-Day RSI or its related term are showing as below:
VEEV's 9-Day RSI is ranked worse than 88.54% of 698
companies
in the Healthcare Providers & Services industry
Industry Median: 50.38
vs VEEV: 70.05
Veeva Systems (NYSE:VEEV) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Veeva Systems 9-Day RSI Related Terms
VEEV vs BTSG, TEM, HQY: 9-Day RSI Comparison
For the Health Information Services subindustry, Veeva Systems's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Veeva Systems's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veeva Systems (VEEV) has a 9-Day RSI of 70.05 as of Jul. 11, 2026. According to the industry distribution chart, Veeva Systems ranks #618 out of 698 companies in the Healthcare Providers & Services industry, placing it in the top 88.5%.
Is Veeva Systems' 9-Day RSI too high?
Veeva Systems' current 9-Day RSI is 70.05. The Healthcare Providers & Services industry median 9-Day RSI is 50.38. Veeva Systems' value of 70.05 is 39% above this industry median. Based on the distribution chart, Veeva Systems ranks #618 out of 698 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Veeva Systems has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' 9-Day RSI compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #618 out of 698 companies for 9-Day RSI. This places Veeva Systems in the lower half of its industry. The industry median 9-Day RSI is 50.38. Veeva Systems' value of 70.05 is 39% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 50.38, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current 9-Day RSI of 70.05 is 39% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 50.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current 9-Day RSI is 70.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (VEEV) is currently considered Significantly Undervalued. The stock's GF Value™ is $286.74, compared to a current price of $190.12 — trading 33.7% below its estimated fair value. The current 9-Day RSI is 70.05 and 39% above the Healthcare Providers & Services industry median of 50.38. Veeva Systems' overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Veeva Systems (VEEV), the current 9-Day RSI is 70.05 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of $190.12 is trading 33.7% below its estimated GF Value™ of $286.74.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for VEEV:
9-Day RSI: 70.05
GF Value™: $286.74 vs. price of $190.12 (33.7% below fair value)
Industry Position: 39% above the Healthcare Providers & Services median (#618 of 698)
No single metric tells the full story. See the VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
83GF Score
Get the complete analysis for VEEV
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VEEV has been successfully added to your 